zofran for semaglutide Nausea: Why It Happens and How to Manage It Compound Semaglutide

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Click the link in my...

Constipation is a common but manageable side effect of Ozempic, a medication for diabetes and weight loss

A study linking statins, the microbiome, and blood sugar control doesnt change clinical practice

To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.

Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine by Dr